And it's being fueled by a strong fundamental tailwind.
There aren't any new S&P 500 earnings reactions to cover, so we want to tell you about one of our favorite earnings reactions from this quarter outside of the S&P 500.
LeMaitre Vascular $LMAT is a small-cap medical device company...
Every weekend, I dig into our insider filings tracker looking for the biggest conviction buys — and this week, the action was impossible to ignore, led by heavyweight moves in biotech and emerging markets.
